A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis
Clinical trial NCT07675954 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07675954
- Sponsor
- Seoul National University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2032-06-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.